CSPC pharmaceutical schedules board meeting for Q3 results approval

CSPC Pharmaceutical Group Limited has announced its board of directors will convene a meeting on Thursday, 20 November 2025. The primary agenda for this meeting is to approve the unaudited third-quarter results of the company and its subsidiaries for the nine months ended 30 September 2025. This announcement was made from Hong Kong on 10 November 2025.

As of the announcement date, the board of directors for CSPC Pharmaceutical Group Limited comprises a mix of executive and independent non-executive directors. The executive directors include Mr. CAI Dong Chen (chairman), Mr. ZHANG Cuilong, Mr. WANG Zhenguo, Mr. WANG Huaiyu, Dr. LI Chunlei, Dr. YAO Bing, Mr. CAI Xin, and Mr. CHEN Weiping.

The independent non-executive directors are Mr. WANG Bo, Mr. CHEN Chuan, Prof. WANG Hongguang, Mr. AU Chun Kwok Alan, Mr. LAW Cheuk Kin Stephen, and Ms. LI Quan. The meeting will address these crucial financial results, which are expected to provide an update on the company's performance over the first three quarters of 2025.